Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Locations

Institute of Developmental & Regenerative Medicine (IDRM), IMS-Tetsuya Nakamura Building, Old Road Campus, Level 3, Roosevelt Drive, Headington, Oxford, OX3 7TY

John Radcliffe Hospital, Level 5 & 6, Headley Way, Headington, Oxford, OX3 9DU

Quan Yao Ho

MBBS, MRCP, MMed, FAMS


MSc (Res) student

I am currently a student with the Translational Research and Immunology Group (TRIG) under Dr Fadi Issa and Dr Joanna Hester. My research focuses on the in-depth characterisation of the immunological changes in the peripheral blood of patients participating in the TWO study and the immune profiling of the cell products used. Regulatory T cell therapy is a promising strategy to optimise immunosuppression in solid organ transplant recipients but relatively little is known about how these cells modulate the human immune system in this setting. This research will improve our understanding of these mechanisms and allow us to optimise the monitoring strategies and individualise therapy for patients receiving cell therapy for immune modulation. 

I completed medical school at the National University of Singapore in 2010 and was conferred specialist accreditation in renal medicine in 2018 and in kidney transplantation in 2021. I am a consultant nephrologist at the Singapore General Hospital and SingHealth Duke-NUS Transplant Centre and hold adjunct faculty appointments in the medical schools in Singapore. Prior to my studies, I was also a core faculty member of the SingHealth renal medicine senior residency programme.